companydata.dkcompanydata.dk

FERTIN PHARMA A/S: Financial statements 2022

CVR: 25834844

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 892,580,000 and a net result of DKK -91,376,000 compared with DKK 37,642,000 the year before. That is a decrease of 4.3% compared with the year before. The profit margin was -10.2%. Equity in the 2022 report amounted to DKK 596,345,000. The solvency ratio was 26.5%. The company had 622 employees in the financial year.

Revenue
DKK 892,580,000
Gross Profit
DKK 25,164,000
Profit/Loss
DKK -91,376,000
Equity
DKK 596,345,000
Total Assets
DKK 2,249,475,000
Employees
622

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022892.6M25.2M-91.4M596.3M622
2021932.5M161.4M37.6M681.4M569
2020991.1M246.4M155.4M770.1M674
2019881.6M190.8M81.3M778.3M661
2018812.5M121.4M45.8M896M609

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on FERTIN PHARMA A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

FERTIN PHARMA A/S: The 2021 annual report is outJun 29, 2022

FERTIN PHARMA A/S has published its annual report for 2021. Revenue came to DKK 932,545,000, and the net result was DKK 37,642,000.

FERTIN PHARMA A/S appoints new auditorMay 27, 2022

As of May 27, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of FERTIN PHARMA A/S.

Auditor steps down at FERTIN PHARMA A/SMay 27, 2022

As of May 27, 2022, EY Godkendt Revisionspartnerselskab has stepped down as auditor of FERTIN PHARMA A/S.

About FERTIN PHARMA A/S

FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.

Source: annual report 2025, Danish Business Authority